These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14756144)

  • 1. Oxaliplatin.
    Graham J; Mushin M; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Jan; 3(1):11-2. PubMed ID: 14756144
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 4. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.
    Field K; Zelenko A; Kosmider S; Court K; Ng LL; Hibbert M; Gibbs P
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):203-9. PubMed ID: 20887502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
    Ducreux M; Louvet C; Bekradda M; Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
    Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of oxaliplatin: an active platinum agent in colorectal cancer.
    Cassidy J
    Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer.
    Becouarn Y; Rougier P
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):23-31. PubMed ID: 9609105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of advanced colorectal cancer.
    O'Dwyer PJ; Stevenson JP
    Cancer Treat Res; 1998; 98():111-52. PubMed ID: 10326667
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 17. [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].
    Longo F; Mansueto G
    Tumori; 2005; 91(3):suppl 1-12. PubMed ID: 16206661
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Aug; 13(8):1116-8. PubMed ID: 10499245
    [No Abstract]   [Full Text] [Related]  

  • 19. Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
    Siu SW; Chan WL; Liu KY; Choy TS; Leung TW; Au KH
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):558-9. PubMed ID: 21524570
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Jul; 13(7):966, 969-70. PubMed ID: 10442343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.